Cited by 103Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Decreased C-Reactive Protein Levels in Alzheimer Disease

Open access

O'Bryant, Sid E., Waring, Stephen C., Hobson, Valerie, Hall, James R., Moore, Carol B., Bottiglieri, Teodoro, Massman, Paul, Diaz-Arrastia, Ramon·2010·Journal of Geriatric Psychiatry and Neurology

DOI 10.1177/0891988709351832PMC PMC3204581

Open this paper in CoChat — free account

Abstract

C-reactive protein (CRP) is an acute-phase reactant that has been found to be associated with Alzheimer disease (AD) in histopathological and longitudinal studies; however, little data exist regarding serum CRP levels in patients with established AD. The current study evaluated CRP levels in 192 patients diagnosed with probable AD (mean age = 75.8 ± 8.2 years; 50% female) as compared to 174 nondemented controls (mean age = 70.6 ± 8.2 years; 63% female). Mean CRP levels were found to be significantly decreased in AD (2.9 µg/mL) versus controls (4.9 µg/mL; P = .003). In adjusted models, elevated CRP significantly predicted poorer (elevated) Clinical Dementia Rating Scale sum of boxes (CDR SB) scores in patients with AD. In controls, CRP was negatively associated with Mini-Mental State Examination (MMSE) scores and positively associated with CDR SB scores. These findings, together with previously published results, are consistent with the hypothesis that midlife elevations in CRP are associated with increased risk of AD development though elevated CRP levels are not useful for prediction in the immediate prodrome years before AD becomes clinically manifest. However, for a subgroup of patients with AD, elevated CRP continues to predict increased dementia severity suggestive of a possible proinflammatory endophenotype in AD.

Integrity signals

Registry

Crossref · 10.1177/0891988709351832

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
[Japanese version of the Neuropsychiatric Inventory--a scoring system for neuropsychiatric disturbance in dementia patients].
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Special Care Units and Traditional Care in Dementia: Relationship with Behavior, Cognition, Functional Status and Quality of Life - A Review
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Glutamate neurotoxicity and diseases of the nervous system
Choi, D. W. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 8,188
A New Clinical Scale for the Staging of Dementia
Hughes, C. P., Berg, L., Danziger, W., Coben, L. A., & Martin, R. L. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.6.566 · Cited by 7,056
Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850

Show all 42 references

Research works printed but not linked: 5

Ridker PM, 1998, J Investig Med, 46, 391
Kuller LH, 1996, Multiple Risk Factor Intervention Trial. Am J Epidemiol, 144, 537
Waring S., 2008, Texas Public Health J, 60, 9
O’Bryant SE, 2009, Journal of Alzheimer’s Disease, 17, 1051
Diaz-Arrastia R., International Conference on Alzheimer’s Disease

Sorted by citations

Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Khan, S., Barve, K. H., & Kumar, M. S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200528142429 · Cited by 820
IL-1β, IL-6, TNF- α and CRP in Elderly Patients with Depression or Alzheimer’s Disease: Systematic Review and Meta-Analysis
Ng, A., Tam, W. W., Zhang, M. W., Ho, C. S., Husain, S. F., McIntyre, R. S., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-30487-6 · Cited by 572
The future of blood‐based biomarkers for Alzheimer's disease
Henriksen, K., O’Bryant, S. E., Hampel, H. J., Trojanowski, J. Q., Montine, T. J., Jeromin, A., Blennow, K., Lönneborg, A., Wyss‐Coray, T., Soares, H. D., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.01.013 · Cited by 327
Self-citation
Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers
Tao, Q., Ang, T. F. A., DeCarli, C., Auerbach, S. H., Devine, S., Stein, T. D., Zhang, X., Massaro, J., Au, R., & Qiu, W. Q. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.3597 · Cited by 239
A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
O’Bryant, S. E., Xiao, G., Barber, R. C., Huebinger, R. M., Wilhelmsen, K. C., Edwards, M., Graff‐Radford, N. R., Doody, R. S., Diaz-Arrastia, R. R., & Initiative, A. D. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028092 · Cited by 156
Self-citation
C‐reactive protein and ageing
Tang, Y., Fung, E., Xu, A., & Lan, H. Y. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12758 · Cited by 146
Increased plasma levels of lipocalin 2 in mild cognitive impairment
Choi, J., Lee, H., & Suk, K. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.023 · Cited by 123
Biomarkers of Vascular Risk, Systemic Inflammation, and Microvascular Pathology and Neuropsychiatric Symptoms in Alzheimer's Disease
Hall, J. R., Wiechmann, A. R., Johnson, L. A., Edwards, M., Barber, R. C., Winter, A. S., Singh, M., & O’Bryant, S. E. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122359 · Cited by 102
Self-citation
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
A Blood-Based Algorithm for the Detection of Alzheimer’s Disease
O’Bryant, S. E., Xiao, G., Barber, R. C., Reisch, J., Hall, J. R., Cullum, C. M., Doody, R. S., Fairchild, T., Adams, P. M., Wilhelmsen, K. C., et al. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000330750 · Cited by 96
Self-citation
Shared biological pathways for frailty and cognitive impairment: A systematic review
Sargent, L. J., Nalls, M. A., Starkweather, A. R., Hobgood, S. E., Thompson, H., Amella, E. J., & Singleton, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.08.001 · Cited by 94
Differences between early and late onset Alzheimer's disease.
Panegyres, P. K., & Chen, H.-Y. (2013) · Europe PMC (PubMed Central) · Cited by 88
Exploring Biomarkers for Alzheimer’s Disease
Sharma, N. (2016) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2016/18828.8166 · Cited by 91
Biomarkers of Alzheimer's Disease Among Mexican Americans
O’Bryant, S. E., Xiao, G., Edwards, M., Devous, M. D., Gupta, V. B., Martins, R. N., Zhang, F., & Barber, R. C. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122074 · Cited by 80
Self-citation
Neuroinflammation in Alzheimer’s disease: Pleiotropic roles for cytokines and neuronal pentraxins
Swanson, A., Wolf, T., Sitzmann, A., & Willette, A. A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.02.015 · Cited by 72
The Role of Inflammatory Mediators in the Pathogenesis of Alzheimer’s Disease
Azizi, G., Navabi, S. S., Al-Shukaili, A. K., Seyedzadeh, M. H., Yazdani, R., & Mirshafiey, A. (2015) · Sultan Qaboos University medical journal · doi:10.18295/squmj.2015.15.03.002 · Cited by 76
Serum Brain-Derived Neurotrophic Factor Levels Are Specifically Associated with Memory Performance among Alzheimer’s Disease Cases
O’Bryant, S. E., Hobson, V. L., Hall, J. R., Barber, R. C., Zhang, S., Johnson, L. A., & Diaz-Arrastia, R. R. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000321980 · Cited by 72
Self-citation
Elevated plasma ferritin in elderly individuals with high neocortical amyloid-β load
Goozee, K. G., Chatterjee, P., James, I., Shen, K., Sohrabi, H. R., Asih, P. R., Dave, P., ManYan, C., Taddei, K., Ayton, S., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.146 · Cited by 69
Systemic Inflammation Is Associated With Longitudinal Changes in Cognitive Performance Among Urban Adults
Beydoun, M. A., Dore, G. A., Canas, J. A., Liang, H., Beydoun, H. A., Evans, M. K., & Zonderman, A. B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00313 · Cited by 67
Peripheral versus central nervous system APOE in Alzheimer’s disease: Interplay across the blood-brain barrier
Chernick, D., Ortiz‐Valle, S., Jeong, A., Qu, W., & Li, L. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134306 · Cited by 64
Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases
Mayo, S., Benito‐León, J., Peña‐Bautista, C., Baquero, M., & Cháfer‐Pericás, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x19666201223154009 · Cited by 62
Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease
Yarchoan, M. M., Louneva, N., Xie, S. X., Swenson, F. J., Hu, W. T., Soares, H. D., Trojanowski, J. Q., Lee, V. M. ‐., Kling, M. A., Shaw, L. M. J., et al. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.05.028 · Cited by 58
A Meta-Analysis of C-Reactive Protein in Patients With Alzheimer’s Disease
Gong, C., Wei, D., Wang, Y., Ma, J., Yuan, C., Zhang, W., Yu, G., & Zhao, Y. (2015) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317515602087 · Cited by 53
Disease Risk Factors Identified Through Shared Genetic Architecture and Electronic Medical Records
Li, L., Ruau, D., Patel, C. J., Weber, S., Chen, R., Tatonetti, N. P., Dudley, J. T., & Butte, A. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007191 · Cited by 55
Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study
Chen, D., Wei, X., Zou, J., Wang, R., Liu, X., Xu, X., Lu, J., Wang, Z., Tang, B., Wang, B. Z., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00247 · Cited by 50
Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study
Huckans, M. S., Fuller, B. E., Chalker, A. L. N., Adams, M. K. M., & Loftis, J. M. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00178 · Cited by 49
A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer’s Disease
O’Bryant, S. E., Zhang, F., Johnson, L. A., Hall, J. R., Edwards, M., Grammas, P., Oh, E. S., Lyketsos, C. G., & Rissman, R. A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180619 · Cited by 50
Self-citation
The Link Between C-Reactive Protein and Alzheimer's Disease Among Mexican Americans
O'Bryant, S. E., for the Texas Alzheimer's Research & Care Consortium, Johnson, L., Edwards, M., Soares, H., Devous, M. D., Ross, S., Rohlfing, G., & Hall, J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122071 · Cited by 47
Self-citation
A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
O’Bryant, S. E., Zhang, F., Petersen, M. E., Hall, J. R., Johnson, L. A., Yaffe, K. S., Mason, D., Braskie, M. N., Barber, R. C., Rissman, R. A., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12382 · Cited by 43
Self-citation
C-reactive protein level is decreased in patients with Alzheimer's disease and related to cognitive function and survival time
Nilsson, K. H., Gustafson, L., & Hultberg, B. L. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.07.011 · Cited by 42
Association of C-Reactive Protein and Motoric Cognitive Risk Syndrome in Community-Dwelling Older Adults: The China Health and Retirement Longitudinal Study
Bai, A., Shi, H., Huang, X., Xu, W., & Deng, Y. (2021) · The journal of nutrition health & aging · doi:10.1007/s12603-021-1678-3 · Cited by 39
Multi‐analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection
Huckans, M. S., Fuller, B. E., Olavarria, H., Sasaki, A. W., Chang, M., Flora, K. D., Kolessar, M., Kříž, D., Anderson, J. R., Vandenbark, A. A., et al. (2013) · Brain and Behavior · doi:10.1002/brb3.200 · Cited by 41
Molecular Links and Biomarkers of Stroke, Vascular Dementia, and Alzheimer's Disease
Vijayan, M., Kumar, S., Bhatti, J. S., & Reddy, P. H. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.014 · Cited by 37
The association of high sensitivity C-reactive protein and incident Alzheimer disease in patients 60 years and older: The HUNT study, Norway
Gabin, J. M., Saltvedt, I. T., Tambs, K., & Holmen, J. (2018) · Immunity & Ageing · doi:10.1186/s12979-017-0106-3 · Cited by 39
Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease
Lathe, R., Schultek, N. M., Balin, B. J., Ehrlich, G. D., Alberi, L. A., Perry, G. L., Breitschwerdt, E. B., Corry, D. B., Doty, R. L., Rissman, R. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13076 · Cited by 39
Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer’s Disease: Testosterone as a Modifier
Asih, P. R., Tegg, M., Sohrabi, H. R., Carruthers, M. E., Gandy, S., Saad, F., Verdile, G., Ittner, L. M., & Martins, R. N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161259 · Cited by 34
Morphometric Changes to Corneal Dendritic Cells in Individuals With Mild Cognitive Impairment
Dehghani, C., Frost, S. M., Jayasena, R., Fowler, C. J., Masters, C. L., Kanagasingam, Y., Jiao, H., Lim, J. K. H., Chinnery, H. R., & Downie, L. E. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.556137 · Cited by 34
Programmed ageing: decline of stem cell renewal, immunosenescence, and Alzheimer's disease
Lathe, R., & Clair, D. S. (2023) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12959 · Cited by 37
Relationship between Serum Levels of Tau Fragments and Clinical Progression of Alzheimer's Disease
Henriksen, K., Byrjalsen, I., Christiansen, C., & Karsdal, M. A. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140984 · Cited by 34
C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia
Fernandes, A. S., Tábuas‐Pereira, M., Duro, D., Lima, M., Gens, H., Santiago, B., Durães, J., Almeida, M. R., Leitão, M. J., Baldeiras, I., et al. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111004 · Cited by 37
Pentraxins and Alzheimer's disease: At the interface between biomarkers and pharmacological targets
Osera, C., Pascale, A., Amadio, M., Venturini, L., Govoni, S. M., & Ricevuti, G. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.12.004 · Cited by 30
Nanomolar aluminum induces expression of the inflammatory systemic biomarker C-reactive protein (CRP) in human brain microvessel endothelial cells (hBMECs)
Alexandrov, P. N., Kruck, T. P. A., & Lukiw, W. J. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.07.013 · Cited by 29
Association between an inflammatory biomarker score and future dementia diagnosis in the population-based UK Biobank cohort of 500,000 people
Mekli, K., Lophatananon, A., Maharani, A., Nazroo, J. Y., & Muir, K. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288045 · Cited by 28
Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer’s Disease Pathology in Older Adults
Dayon, L., Wojcik, J., Galindo, A. N., Corthésy, J., Cominetti, O., Oikonomidi, A., Henry, H., Migliavacca, E., Bowman, G. L., & Popp, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170426 · Cited by 28
The Hachinski Ischemic Scale and cognition: the influence of ethnicity
Johnson, L. A., Cushing, B., Rohlfing, G., Edwards, M., Davenloo, H., D'Agostino, D., Hall, J. R., & O’Bryant, S. E. (2013) · Age and Ageing · doi:10.1093/ageing/aft189 · Cited by 24
Self-citation
A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer’s Disease
Johnson, L. A., Hall, J. R., & O’Bryant, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068848 · Cited by 25
Self-citation
Decreased plasma C‐reactive protein levels in APOE ε4 allele carriers
Martiskainen, H., Takalo, M., Solomon, A., Stančáková, A., Marttinen, M., Natunen, T., Haapasalo, A., Herukka, S., Kuusisto, J., Soininen, H. S., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.639 · Cited by 25
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS) study
Petersen, M. E., Zhang, F., Schupf, N., Krinsky‐McHale, S. J., Hall, J. R., Mapstone, M. E., Cheema, A. K., Silverman, W. P., Lott, I. T., Rafii, M. S., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12039 · Cited by 22
Self-citation
Elevated C-Reactive Protein in Alzheimer’s Disease Without Depression in Older Adults: Findings From the Health and Retirement Study
Natale, G., Clouston, S., & Smith, D. M. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab282 · Cited by 21
The Role of Inflammation and Infection in Age-Related Neurodegenerative Diseases: Lessons From Bacterial Meningitis Applied to Alzheimer Disease and Age-Related Macular Degeneration
Too, L. K., Hunt, N. H., & Simunovic, M. P. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.635486 · Cited by 21
The impact of increasing levels of blood C-reactive protein on the inflammatory loci SPI1 and CD33 in Alzheimer’s disease
Huang, J., Tao, Q., Ang, T. F. A., Farrell, J. J., Zhu, C., Wang, Y., Stein, T. D., Lunetta, K. L., Massaro, J. M., Mez, J., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02281-6 · Cited by 21
Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia
Greenblatt, C. L., & Lathe, R. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231323 · Cited by 21
A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer’s Disease
Araújo, D. C., Initiative, A. D. N., Veloso, A., Gomes, K. B., de Souza, L. C., Ziviani, N., & Caramelli, P. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220256 · Cited by 17
Molecular Markers of Amnestic Mild Cognitive Impairment among Mexican Americans
Edwards, M., Hall, J. R., Williams, B. J., Johnson, L. A., & O’Bryant, S. E. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150553 · Cited by 17
Self-citation
APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid1
Berger, M., Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszeski, J. L., VanDusen, K. W., Thompson, J. W., Moseley, M. A., Devinney, M. J., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200747 · Cited by 15
Chronic immune stimulation as a contributing cause of chronic disease in opiate addiction including multi-system ageing
Reece, A. S. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.07.047 · Cited by 17
Chronically raised C-reactive protein is inversely associated with cortical β-amyloid in older adults with subjective memory complaints
Hooper, C., Barreto, P. D. S., Cantet, C., Cesari, M., Payoux, P., Salabert, A., & Vellas, B. J. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.04.014 · Cited by 19
Molecular Neuropsychology: Creation of Test-Specific Blood Biomarker Algorithms
O’Bryant, S. E., Xiao, G., Barber, R. C., Cullum, C. M., Weiner, M., Hall, J. R., Edwards, M., Grammas, P., Wilhelmsen, K. C., Doody, R. S., et al. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000345605 · Cited by 16
Self-citation
Impact of hs-CRP concentration on brain structure alterations and cognitive trajectory in Alzheimer’s disease
Zhang, Y., Tatewaki, Y., Nakase, T., Liu, Y., Tomita, N., Thyreau, B., Zheng, H., Muranaka, M., Takano, Y., Nagasaka, T., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1227325 · Cited by 14
Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD)
Tachibana, A., Iga, J., Ozaki, T., Yoshida, T., Yoshino, Y., Shimizu, H., Mori, T., Furuta, Y., Shibata, M., Ohara, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57922-1 · Cited by 16
Biomarkers of Basic Activities of Daily Living in Alzheimer's Disease
Hall, J. R., Johnson, L. A., Barber, R. C., Vo, H. T., Winter, A. S., & O’Bryant, S. E. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111481 · Cited by 14
Self-citation
A depressive endophenotype of poorer cognition among cognitively healthy community‐dwelling adults: results from the Western Australia memory study
Johnson, L. A., Sohrabi, H. R., Hall, J. R., Taddei, K., Edwards, M., O’Bryant, S. E., & Martins, R. N. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4231 · Cited by 12
Self-citation
Investigating Changes in the Serum Inflammatory Factors in Alzheimer’s Disease and Their Correlation with Cognitive Function
Hao, J., Qiao, Y., Li, T., Yang, J., Song, Y., Jia, L., & Jia, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210552 · Cited by 12
Air pollution is linked to cognitive decline independent of hypersensitive C-reactive protein: insights from middle-aged and older Chinese
Huang, L., Hu, X., Liu, J., Wang, J., Zhou, Y., Li, G., Dong, G., & Dong, H. (2024) · Environmental Health · doi:10.1186/s12940-024-01148-1 · Cited by 11
C-Reactive Protein Levels in the First Three Hours After Acute Cerebral Infarction
Camerlingo, M., Valente, L., Tognozzi, M., Beretta, G. L., Moschini, L., & Cesana, B. M. (2010) · International Journal of Neuroscience · doi:10.3109/00207454.2010.530005 · Cited by 11
Molecular markers of neuropsychological functioning and Alzheimer's disease
Edwards, M., Balldin, V. H., Hall, J. R., & O’Bryant, S. E. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2014.11.001 · Cited by 10
Self-citation
“Let's talk about sex, inflammaging, and cognition, baby”: A meta-analysis and meta-regression of 106 case-control studies on mild cognitive impairment and Alzheimer's disease
Childs, R., Karamacoska, D., Lim, C. K., & Steiner, G. Z. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100819 · Cited by 9
Differences in C-reactive Protein Level in Patients with Alzheimers Disease and Mild Cognitive Impairment
Shin, H. K. A. (2015) · African Journal of Psychiatry · doi:10.4172/psychiatry.1000194 · Cited by 9
Integrative blood-based characterization of oxidative mitochondrial DNA damage variants implicates Mexican American’s metabolic risk for developing Alzheimer’s disease
Reid, D. M., Barber, R. C., Jones, H. P., Thorpe, R. J., Sun, J., Zhou, Z., & Phillips, N. (2023) · Scientific Reports · doi:10.1038/s41598-023-41190-6 · Cited by 9
Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer’s Disease
Handy, Á., Initiative, O. B. O. T. A. D. N., Lord, J., Green, R., Xu, J., Aarsland, D., Velayudhan, L., Hye, A., Dobson, R., & Proitsi, P. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210462 · Cited by 9
Translational research into frailty from bench to bedside: Salivary biomarkers for inflammaging
Cárdenas, A. N., Bareke, H., Juanes‐Velasco, P., Landeira‐Viñuela, A., Hernández, Á., Montalvillo, E., Góngora, R., Arroyo-Anlló, E. M., Puente-González, A. S., Sánchez, R. M., et al. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.112040 · Cited by 9
Advances in biomarkers and diagnostic significance of organ aging
Chen, Y., Li, J., Liu, X., Geng, Z., Xu, K., & Su, J. (2023) · Fundamental Research · doi:10.1016/j.fmre.2023.03.009 · Cited by 9
Optimization of prebiotics in soybean milk using mixture experiments
Sugkhaphan, P., & Kijroongrojana, K. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 6
Comparison of commonly measured plasma and cerebrospinal fluid proteins and their significance for the characterization of cognitive impairment status
Rehman, H., Initiative, F. T. A. D. N., Ang, T. F. A., Tao, Q., Espenilla, A. L., Au, R., Farrer, L. A., Zhang, X., & Qiu, W. Q. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-230837 · Cited by 7
Linking atherosclerosis to Alzheimer's disease: focus on biomarkers
Emanuele, E. (2011) · Frontiers in Bioscience-Elite · doi:10.2741/411 · Cited by 7
Systemic inflammatory markers and their association with Alzheimer’s disease: A cross-sectional analysis
Khatri, A., Prakash, O., Agarwal, R., & Kushwaha, S. S. (2024) · Indian Journal of Psychiatry · doi:10.4103/indianjpsychiatry.indianjpsychiatry_975_23 · Cited by 6
Inflammation Friend or Foe?
Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00007-0 · Cited by 8
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in aging
Supiyev, A., Karlsson, R., Wang, Y., Koch, E. M., Hägg, S., & Kauppi, K. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.02.006 · Cited by 5
C-Reactive Protein: An Overview
Vashist, S. K. (2013) · Journal of Basic & Applied Sciences · doi:10.6000/1927-5129.2013.09.64 · Cited by 5
Amaryllidaceae, Lycopodiaceae Alkaloids and Coumarins—A Comparative Assessment of Safety and Pharmacological Activity
Herbet, M., Widelski, J., Piątkowska‐Chmiel, I., Pawłowski, K., Dymek, A., & Mroczek, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154291 · Cited by 5
Recent Advancements in the Early Diagnosis and Treatment of Alzheimer's Disease
Wu, Y., Fu, L., Li, Q., Gao, X., Zhang, Y., Jin, C., Ding, F., Hong, S. C., Cai, H., & Li, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300181 · Cited by 4
Peripheral Inflammatory Biomarkers of Alzheimer’s Disease
Hao, J., Guo, Y., Guo, K., & Yang, Q. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215422 · Cited by 5
Associations of circulating c-reactive protein levels with central Alzheimer’s disease biomarkers
Choi, H., Byun, M. S., Yi, D., Ahn, H., Jung, G., Park, S., Jung, J. H., Keum, M., Sohn, B. K., Kim, Y., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100368 · Cited by 4
Soluble Interleukin‐6 Receptor Levels and Risk of Dementia: One More Signpost on a Long Road Ahead
Thambisetty, M., & Ferrucci, L. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12737 · Cited by 4
C-Reactive Protein and Neurodegenerative Diseases
Cardoso, I. L., & Leal, M. F. C. (2020) · Springer eBooks · doi:10.1007/978-981-15-6787-2_2 · Cited by 4
Novel Plasma Biomarkers for Alzheimer’s Disease: Insights from Organotypic Brain Slice and Microcontact Printing Techniques
Yılmaz, N., Steiner, K., Marksteiner, J., Faserl, K., Sarg, B., & Humpel, C. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl36257 · Cited by 4
KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease Patients
Malek‐Ahmadi, M. H., Patel, A., & Sabbagh, M. N. (2013) · International Journal of Alzheimer s Disease · doi:10.1155/2013/242303 · Cited by 3
Regional Differences in Microbial Infiltration of Brain Tissue from Alzheimer’s Disease Patients and Control Individuals
Jones, T. B., Chu, P., Wilkey, B., Lynch, L. M., & Jentarra, G. M. (2024) · Brain Sciences · doi:10.3390/brainsci14070677 · Cited by 3
A Clinical Significance of High-Sensitivity C-reactive Protein Level in Alzheimer's Disease and Vascular Dementia
Wang, M.-J., Lim, E. Y., Kim, Y., Song, I., Chung, S., & Yang, Y. (2012) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2012.11.4.131 · Cited by 2
Fluid biomarkers for Alzheimer's disease in Down syndrome: Current status and novel trends
Iulita, M. F., Granholm, A., Carmona‐Iragui, M., Hamlett, E. D., Fortea, J., & Ledreux, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00010-4 · Cited by 2
Acute Phase Protein’s Levels as Potential Biomarkers for Early Diagnosis of Neurodegenerative Diseases
Pablos, D., Barcia, C., Je, Y., Ros-Bernal, F., Ma, C. D., Fernández-Villalba, E., & Herrero, M. (2011) · InTech eBooks · doi:10.5772/22626 · Cited by 2
The Role of Inflammatory Biomarkers as a Diagnostic Tool for Possible Late-Life Cognitive Decline and Dementias
Katsoulaki, M., Kastrinis, A., Konstantoudaki, X., & Τσεκούρα, Μ. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78787-5_6 · Cited by 1
The Role of Diet, Erythrocyte Membrane Fatty Acid Composition, and Alzheimer's-related Genes in Systemic Inflammation in the Cache County Memory Study
Jalloun, R. A. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/4558-0376
2010 Faculty Bibliography of Publications
Lindsey, M., & Mason, T. (2011) · Digital Commons @ UNT Health Science Center
Original Article Differences between early and late onset Alzheimer's disease
Panegyres, P. K., & Chen, H.-Y. (2013)
Evaluating the Role of C-reactive Protein on Cognition and Depressive Symptoms Among Women by Mexican American Ethnicity
Huerta, S. (2014) · doi:10.12794/metadc700036
Compilação sobre possíveis biomarcadores para doença de Alzheimer
Ribeiro, M., & Urbano, P. R. P. (2020) · Revista Brasileira de Ciências Biomédicas · doi:10.46675/rbcbm.v1i2.13
Current awareness in geriatric psychiatry
John Wiley & Sons, L. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2396
The Role of Periodontitis as Modifiable Risk Factor for Alzheimer’s Disease- A Recent Update
Rai, P., Chande, Y., Mukadam, M., & Shetty, A. (2023) · Journal Of Advanced Zoology · doi:10.17762/jaz.v44i5.2806
Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer’s disease
Huang, J., Rehman, H., Doan, C., Stein, T. D., Mez, J., Ang, T. F. A., Tao, Q., Au, R., Farrer, L. A., Zhang, X., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107257

Authors: O'Bryant, S. E., Waring, S. C., Hobson, V., Hall, J. R., Moore, C. B., Bottiglieri, T., Massman, P., & Diaz-Arrastia, R.
Affiliations: Department of Neurology, F. Marie Hall Institute for Rural & Community Health, Texas Tech University Health Sciences Center, Lubbock, Texas,
Marshfield Clinic Research Foundation (US)
Texas Tech University (US)
University of North Texas Health Science Center (US)
The University of Texas Southwestern Medical Center (US)
Baylor University Medical Center (US)
Baylor College of Medicine (US)
ORCID: Waring, Stephen C.
Hall, James R.
Bottiglieri, Teodoro
Diaz-Arrastia, Ramon
Venue: Journal of Geriatric Psychiatry and Neurology
Publisher: SAGE Publications
Published: 2009-11-20
Volume: 23
Issue: 1
Pages: 49-53
ISSN: 0891-9887 (ISSN-L)
1552-5708
DOI: 10.1177/0891988709351832
PMC: PMC3204581
OpenAlex: W2056433678
Cited by: 103
References: 42
Citations by year: 2026: 4 · 2025: 2 · 2024: 6 · 2023: 10 · 2022: 6 · 2021: 9 · 2020: 8 · 2019: 1 · 2018: 9 · 2017: 6 · 2016: 1 · 2015: 8 · 2014: 5 · 2013: 13 · 2012: 2
FWCI: 3.09
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations: Journal of Geriatric Psychiatry and Neurology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01 AG17869, P30AG012300, P30AG-12300)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: C-reactive protein, Alzheimer's disease, acute phase proteins, dementia severity, Clinical Dementia Rating, Mini-Mental State Examination, inflammation, prodromal Alzheimer's disease, endophenotypes, serum biomarkers
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, C-Reactive Protein, Dementia, Female, Humans, Immunoassay, Male, Mental Status Schedule, Middle Aged, Predictive Value of Tests, Psychiatric Status Rating Scales, Severity of Illness Index, Time Factors, Biomarkers, Linear Models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Decreased C-Reactive Protein Levels in Alzheimer Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks